PROTAC antibody conjugates and methods of use
Abstract:
The subject matter described herein is directed to antibody-PROTAC conjugates (PACs), to pharmaceutical compositions containing them, and to their use in treating diseases and conditions where targeted protein degradation is beneficial.
Public/Granted literature
Information query
Patent Agency Ranking
0/0